Notice of Intent to Sole Source
General Information
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Feb 23, 2022 11:17 am EST
- Original Published Date: Feb 23, 2022 02:20 am EST
- Updated Response Date: Mar 01, 2022 10:00 am EST
- Original Response Date: Feb 28, 2022 10:00 am EST
- Inactive Policy: 15 days after response date
- Updated Inactive Date:
- Original Inactive Date:
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of Performance: Silver Spring , MD 20993USA
Description
The purpose of this synopsis is to announce the Food and Drug Administration's intent to issue a Sole Source Purchase Order for Fresh Primary Human Hepatocyte Cultures.
THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS, however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency by Tuesday, March 1, 2022 @ 10:00 AM Eastern Time to Nina Montgomery, Contract Specialist, Email: Nina.Montgomery@fda.hhs.gov.
Attachments/Links
Contact Information
Contracting Office Address
- 5630 Fishers Lane
- Rockville , MD 20841
- US
Primary Point of Contact
- Nina Montgomery
- nina.montgomery@fda.hhs.gov
- Phone Number 2404028086
Secondary Point of Contact
History
- Mar 16, 2022 11:55 pm EDTSpecial Notice (Updated)
- Feb 23, 2022 07:46 am ESTSpecial Notice (Updated)
- Feb 23, 2022 02:20 am ESTSpecial Notice (Original)